Inflammation from viral infections promotes cancer metastasis, offering answers to why some cancers reawaken in humans.

New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...

David Baker’s Nobel Prize-winning lab has generated AI-designed proteins to enhance the immune system's ability to detect and ...

AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

In a paper published in Science Bulletin, the research team led by Professor Wen Zhang from the Department of Rheumatology and Immunology at Peking Union Medical College Hospital (PUMCH) has made ...

However, in the control group we also observed a reduction in the percentages of CD8+ T cells co-expressing a T-cell activation marker CD38 and a strong reduction in the plasma levels of sCD14.

To assess T cell activation markers, Jurkat and primary CD4+ T cells were incubated with diatom-based aAPCs. Both early and late activation markers (CD69 and CD25, respectively) were measured using RT ...

Expression of exhaustion markers alone does not necessarily mean the cells are functionally exhausted, as these markers can be associated with T-cell activation.

Analysis of early cell-surface T cell activation markers CD69 and CD25 in the context of Her2 High cells showed that a 10-fold higher concentration of Format D was required to induce robust ...

Virtual event with Key Opinion Leaders to discuss cell therapy landscape and shortcomings of CAR-T therapies set for May 28, 2025 HOUSTON, May 19, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC.